Publications by authors named "David Rimm"

Claim this Profile
V
Validation and Prospective Testing of a High-Sensitivity, Quantitative Analytic Assay for HER2 on Histopathology Slides.
Nay N N Chan, Patricia Gaule, Julia Benanto, Liam Scott, Charles J Robbins, David L Rimm

Lab Invest· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).
Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales, Joe Yeong, Guray Akturk, David L Rimm

J Immunother Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed Molecular Subtypes Coexist in Estrogen Receptor Heterogeneous Primary Breast Cancers.
Julia Foldi, Kaitlyn Xiong, Matthew Liu, Charles J Robbins, Fangyuan Chen, David L Rimm

JCO Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathomic immune biomarkers define recurrence risk in early-stage melanoma.
Thazin Nwe Aung, Ajay Singh, Gerardo Espinoza, Chenxin Zhang, Tianyun Jiang, David Rimm

Oncologist· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer.
Thazin N Aung, James Monkman, Jonathan Warrell, Ioannis Vathiotis, Katherine M Bates, David L Rimm

Nat Genet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck.
Aarti Bhatia, Ranee Mehra, Jessica Bauman, Saad A Khan, Wei Wei, David L Rimm

Head Neck· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative assessment of HER2 expression in invasive ductal carcinoma and co-existing DCIS.
Haiying Zhan, Nay Nwe Nyein Chan, Revekka Khaimova, Thazin N Aung, Patricia Gaule, David L Rimm

Breast Cancer Res Treat· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of DNA damage response signals and oxidative stress status with nivolumab efficacy in patients with Head and Neck Squamous Cell Carcinoma.
Christina Papanikolaou, Panagiota Economopoulou, Aris Spathis, Ioannis Kotsantis, Niki Gavrielatou, David Rimm

Br J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence Algorithm Predicts Response to Immune Checkpoint Inhibitors.
Faisal Fa'ak, Nicolas Coudray, George Jour, Milad Ibrahim, Irineu Illa-Bochaca, David L Rimm

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor infiltrating lymphocytes in breast cancer: A narrative review with focus on analytic validity, clinical validity, and clinical utility.
Brian S Finkelman, Huina Zhang, David G Hicks, David L Rimm, Bradley M Turner

Hum Pathol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Protein Expression of Antibody-Drug Conjugate Targets in EGFR Mutated and Wild-type Non-Small Cell Lung Cancer.
Ioannis P Trontzas, Mengni He, Anna Wurtz, Charles J Robbins, Nathaniel Robinson, David L Rimm

Clin Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma.
Thazin N Aung, Matthew Liu, David Su, Saba Shafi, Ceren Boyaci, David L Rimm

JAMA Netw Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Multiplex Immunofluorescence Assay for Trophoblast Cell-Surface Antigen 2 and Human Epidermal Growth Factor Receptor 2 Expression in Breast Cancer: Toward Guiding Patient Selection for Antibody-Drug Conjugate Therapies.
Charles J Robbins, Mengni He, Nay Chan, Revekka Khaimova, Katherine Bates, David L Rimm

JCO Precis Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 testing: evolution and update for a companion diagnostic assay.
Charles J Robbins, Katherine M Bates, David L Rimm

Nat Rev Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Touching (Proximity) as a Companion Diagnostic Test.
Niki Gavrielatou, Parmees Fazeli, David L Rimm

J Thorac Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and Prospective Testing of a High Sensitivity, Quantitative Analytic Assay for HER2 on Histopathology Slides.
Nay N N Chan, Patricia Gaule, Julia Benanto, Liam Scott, Charles J Robbins, David L Rimm

medRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach.
Miguel Lopez de Rodas, Maria Villalba-Esparza, Miguel F Sanmamed, Lieping Chen, David L Rimm

Nat Rev Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.
Ioannis Zerdes, Alexios Matikas, Artur Mezheyeuski, Georgios Manikis, Balazs Acs, David L Rimm

NPJ Breast Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing.
Janis M Taube, Joel C Sunshine, Michael Angelo, Guray Akturk, Margaret Eminizer, David L Rimm

J Immunother Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?
Joan Martínez Vidal, Nikos Tsiknakis, Johan Staaf, Ana Bosch, Anna Ehinger, David L Rimm

EClinicalMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Measurement of HER2 Expression in Non-Small Cell Lung Cancer With a High-Sensitivity Assay.
Matthew Liu, Ioannis Vathiotis, Charles J Robbins, Nay Nwe Nyein Chan, Myrto Moutafi, David L Rimm

Mod Pathol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma.
Thazin N Aung, Jonathan Warrell, Sandra Martinez-Morilla, Niki Gavrielatou, Ioannis Vathiotis, David L Rimm

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCAM (basal cell adhesion molecule) protein expression in different tumor populations.
Sneha Burela, Mengni He, Ioannis P Trontzas, Niki Gavrielatou, Kurt A Schalper, David L Rimm

Discov Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC).
Myrto K Moutafi, Katherine M Bates, Thazin Nwe Aung, Rolando Garcia Milian, Vasiliki Xirou, David L Rimm

J Immunother Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers.
Vasiliki Xirou, Myrto Moutafi, Yalai Bai, Thazin Nwe Aung, Sneha Burela, David L Rimm

Oral Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis